SEC Company Response from Inotiv, Inc. (NOTV) (CIK 0000720154) (NOTV) — Feb 21, 2013
Inotiv, Inc. (NOTV) (CIK 0000720154)
Date: Feb. 21, 2013 · CIK: 0000720154 · Accession: 0001144204-13-010438
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 000-23357
Letter
Item 4.01 Form 8-K Filed February 12, 2013 File No. 000-23357
Re: Bioanalytical Systems, Inc.
Dear Mr. Rodriguez:
Set forth below is the response of Bioanalytical Systems, Inc. (the "Company") to the comments of the Staff contained in the Staff’s letter to the Company, dated February 14, 2013, relating to the Company's Form 8-K filed on February 12, 2013 (File No. 000-23357). For convenience of reference, the text of the comments in the Staff’s letter has been reproduced in bold type herein.
Comment
1. Please confirm that you will amend this Item 4.01 8-K to:
· Disclose the effective date of the dismissal of Crowe Horwarth LLP once they have completed their review services for the quarterly period ended March 31, 2013; and
· Update the interim period related to paragraphs (a)(1)(iv) and (a)(2) of Item 304 of Regulation S-K through the effective date of dismissal.
Response
The disclosure has been revised to reflect the effective date of the resignation of Crowe Horwath LLP and the information required by paragraph (a)(1)(iv) of Item 304 of Regulation S-K through such date. This revised disclosure will be filed by the Company on its Form 8-K/A. The information required by paragraph (a)(2) of Item 304 of Regulation S-K has not been provided because the Company has not yet engaged a new auditor.
Comment
2. Upon amending your filing, please include, as Exhibit 16, an updated letter from your former accountants, Crowe Horwarth, LLP, addressing the revised 8-K disclosure, as required by Item 304(a)(3) of Regulation S-K.
Response
The Company provided Crowe with a copy of its report to be filed on Form 8-K/A and requested that Crowe furnish it with a letter addressing the revised disclosure. A copy of Crowe’s letter will be attached as an exhibit to the Form 8-K/A.
********
765.463.4527 800.845.4246 FAX 765.497.1102 www,BASInc.com 2701 Kent Avenue West Lafayette, IN 47906
Securities and Exchange Commission
February 21, 2013
Page 2
The Company acknowledges that it is responsible for the adequacy and accuracy of all disclosures in the filing and that neither changes to its disclosure in response to staff comments nor staff comments foreclose the Commission from taking any action with respect to the filing. The Company hereby acknowledges that it may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
If you have any questions regarding the Company's response in this letter, please do not hesitate to contact me.
Sincerely,
/s/ Jacqueline M. Lemke
Show Raw Text
CORRESP
1
filename1.htm
February 21, 2013
Writer's Direct Number: (765) 497-5829
Email: jlemke@basinc.com
BY EDGAR AND FEDEX
Mr. Gus Rodriguez, Accounting Branch Chief
U.S. Securities and Exchange Commission
Washington, D.C. 20549
Re:
Bioanalytical Systems, Inc.
Item 4.01 Form 8-K
Filed February 12, 2013
File No. 000-23357
Dear Mr. Rodriguez:
Set forth below is
the response of Bioanalytical Systems, Inc. (the "Company") to the comments of the Staff contained in the Staff’s
letter to the Company, dated February 14, 2013, relating to the Company's Form 8-K filed on February 12, 2013 (File No. 000-23357).
For convenience of reference, the text of the comments in the Staff’s letter has been reproduced in bold type herein.
Comment
1. Please confirm that you will amend this Item 4.01
8-K to:
· Disclose the effective date of the dismissal of Crowe
Horwarth LLP once they have completed their review services for the quarterly period ended March 31, 2013; and
· Update the interim period related to paragraphs (a)(1)(iv)
and (a)(2) of Item 304 of Regulation S-K through the effective date of dismissal.
Response
The disclosure has
been revised to reflect the effective date of the resignation of Crowe Horwath LLP and the information required by paragraph (a)(1)(iv)
of Item 304 of Regulation S-K through such date. This revised disclosure will be filed by the Company on its Form 8-K/A. The information
required by paragraph (a)(2) of Item 304 of Regulation S-K has not been provided because the Company has not yet engaged a new
auditor.
Comment
2. Upon amending your filing, please include, as Exhibit
16, an updated letter from your former accountants, Crowe Horwarth, LLP, addressing the revised 8-K disclosure, as required by
Item 304(a)(3) of Regulation S-K.
Response
The Company provided Crowe with a copy of its report to be filed on Form 8-K/A and requested that Crowe furnish it with a letter addressing the revised disclosure. A copy of Crowe’s letter will be attached as an exhibit to the Form 8-K/A.
********
765.463.4527
800.845.4246
FAX 765.497.1102
www,BASInc.com
2701 Kent Avenue
West Lafayette, IN 47906
Securities and Exchange Commission
February 21, 2013
Page 2
The Company acknowledges
that it is responsible for the adequacy and accuracy of all disclosures in the filing and that neither changes to its disclosure
in response to staff comments nor staff comments foreclose the Commission from taking any action with respect to the filing. The
Company hereby acknowledges that it may not assert staff comments as a defense in any proceeding initiated by the Commission or
any person under the federal securities laws of the United States.
If you have any questions
regarding the Company's response in this letter, please do not hesitate to contact me.
Sincerely,
/s/ Jacqueline M. Lemke
Jacqueline M. Lemke
President and Chief Executive Officer